The impairment of insulin signaling in Alzheimer's disease

被引：69

作者：

Candeias, Emanuel ^{[1
]}

Duarte, Ana I. ^{[1
]}

Carvalho, Cristina ^{[1
,2
]}

Correia, Sonia C. ^{[1
,2
]}

Cardoso, Susana ^{[1
,2
]}

Santos, Renato X. ^{[1
,2
]}

Placido, Ana I. ^{[1
]}

Perry, George ^{[4
]}

Moreira, Paula I. ^{[1
,3
]}

机构：

[1] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal

[2] Univ Coimbra, Fac Sci & Technol, Dept Life Sci, P-3004517 Coimbra, Portugal

[3] Univ Coimbra, Fac Med, Physiol Lab, P-3004517 Coimbra, Portugal

[4] Univ Texas San Antonio, Coll Sci, San Antonio, TX USA

来源：

IUBMB LIFE | 2012年 / 64卷 / 12期

关键词：

aging; Alzheimer's disease; type; 2; diabetes; insulin signaling; THERAPEUTIC TARGET; GLUCOSE-METABOLISM; BRAIN; RESISTANCE; MITOCHONDRIA; DYSFUNCTION; DEMENTIA; RECEPTOR; PATHWAY; RISK;

D O I：

10.1002/iub.1098

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Alterations of the insulin signaling cascade underlie cognitive decline and the development of several neurodegenerative diseases. In recent years, a great interest has been put in studying the interaction between diabetes and Alzheimer's disease (AD). In fact, evidence shows that both diseases present several biochemical similarities including defects in the insulin signaling pathway. Here, we give an overview of the main functions of insulin in the central nervous system. The impact of insulin signaling impairment in brain aging and AD is also discussed. Finally, we present evidence supporting the notion that insulin is a link between diabetes and AD. (C) 2012 IUBMB IUBMB Life, 64(12): 951957, 2012

引用

页码：951 / 957

页数：7

共 50 条

[31] Incretin and insulin signaling as novel therapeutic targets for Alzheimer’s and Parkinson’s disease
Joseph Nowell
Eleanor Blunt
Paul Edison
[J]. Molecular Psychiatry, 2023, 28 : 217 - 229
[32] Effects of Intranasal Insulin on Brain Insulin Signaling in an Aged Mouse Model of Alzheimer's Disease
Nirkhe, S.
Rhea, E. M.
Banks, W. A.
[J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2016, 64 : S260 - S260
[33] Alzheimer's disease and impairment of the Self
Fargeau, M. N.
Jaafari, N.
Ragot, S.
Houeto, J. L.
Pluchon, C.
Gil, R.
[J]. CONSCIOUSNESS AND COGNITION, 2010, 19 (04) : 969 - 976
[34] Alzheimer's disease and visual impairment
Leruez, S.
Annweiller, C.
Etcharry-Bouyx, F.
Verny, C.
Beauchet, O.
Milea, D.
[J]. JOURNAL FRANCAIS D OPHTALMOLOGIE, 2012, 35 (04): : 308 - 311
[35] Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer's disease
Akhtar, Ansab
Sah, Sangeeta Pilkhwal
[J]. NEUROCHEMISTRY INTERNATIONAL, 2020, 135
[36] Alzheimer's Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies
Shieh, Jonathan Chang-Cheng
Huang, Pai-Tsang
Lin, Yung-Feng
[J]. MOLECULAR NEUROBIOLOGY, 2020, 57 (04) : 1966 - 1977
[37] Alzheimer’s Disease and Diabetes: Insulin Signaling as the Bridge Linking Two Pathologies
Jonathan Chang-Cheng Shieh
Pai-Tsang Huang
Yung-Feng Lin
[J]. Molecular Neurobiology, 2020, 57 : 1966 - 1977
[38] Hydroxytyrosol restores proper insulin signaling in an astrocytic model of Alzheimer's disease
Carmen Crespo, M.
Tome-Carneiro, Joao
Pintado, Cristina
Davalos, Alberto
Visioli, Francesco
Burgos-Ramos, Emma
[J]. BIOFACTORS, 2017, 43 (04) : 540 - 548
[39] The Strategies for Treating "Alzheimer's Disease": Insulin Signaling May Be a Feasible Target
You, Guanying
Yao, Jinyi
Liu, Qiong
Li, Nan
[J]. CURRENT ISSUES IN MOLECULAR BIOLOGY, 2022, 44 (12) : 6172 - 6188
[40] Brain Insulin Signaling and Alzheimer's Disease: Current Evidence and Future Directions
Helgi B. Schiöth
Suzanne Craft
Samantha J. Brooks
William H. Frey
Christian Benedict
[J]. Molecular Neurobiology, 2012, 46 : 4 - 10

← 1 2 3 4 5 →